中线移位大于3 mm可独立预测缺血性卒中预后
该研究合并六项急性卒中临床试验与两家学术转诊中心血管内取栓登记数据,共1977例患者。中线移位(MLS)取自原始试验数据或卒中发作后中位47.0小时(IQR 27.0-75.1)的CT或MRI测量。校正基线临床和人口学因素后,MLS存在是不良预后的独立预测因子(aOR 4.46,95%CI 3.56-5.59,p<0.001);MLS大于3 mm是显著预测不良预后的关键阈值(aOR 3.20,95%CI 1.31-7.82,p=0.011)。
要点
- 急性卒中患者影像学出现中线移位时,不良预后风险独立增加(aOR 4.46,95%CI 3.56-5.59,p<0.001),与基线临床和人口学因素无关。
- 中线移位大于3 mm是预测不良预后的关键阈值(aOR 3.20,95%CI 1.31-7.82,p=0.011),适用于该研究涵盖的广泛急性卒中人群。
- MLS测量时间中位为卒中发作后47.0小时(IQR 27.0-75.1),临床解读此阈值时需考虑影像采集时间。
- 该阈值可能对未来抗水肿治疗试验的设计和解读有参考价值。
适用人群与场景
- 来自六项急性卒中临床试验和两家学术转诊中心血管内取栓登记处的急性卒中患者,共1977例。
诊断标准与关键阈值
- 中线移位(MLS)从原始试验数据或卒中发作后中位47.0小时(IQR 27.0-75.1)的CT或MRI上测量;MLS大于3 mm为预测不良预后的关键阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为患者水平数据合并队列,纳入六项急性卒中临床试验与两家学术转诊中心血管内取栓登记数据,共1977例患者;MLS存在是不良预后的独立预测因子(aOR 4.46,95%CI 3.56-5.59,p<0.001);MLS大于3 mm显著预测不良预后(aOR 3.20,95%CI 1.31-7.82,p=0.011)。
证据类型、等级与局限
- 证据类型为多中心临床试验数据与登记数据合并的队列分析;局限包括MLS测量时间存在异质性(中位47.0小时,IQR 27.0-75.1),原文未报告其他局限。
对床旁实践的改变
- 对于急性卒中患者,影像学发现中线移位大于3 mm提示不良预后风险显著增高,可辅助临床沟通与抗水肿治疗试验设计;原文未提供基于该阈值的具体治疗推荐。
指南或共识出处
- Midline Shift Greater than 3 mm Independently Predicts Outcome After Ischemic Stroke(Neurocrit Care)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cerebral edema is associated with worse outcome after acute stroke; however, the minimum clinically relevant threshold remains unknown. This study aimed to identify the minimal degree of midline shift (MLS) that predicts outcome in a cohort encompassing a broad range of patients with acute stroke.
METHODS: Patient-level data from six acute stroke clinical trials were combined with endovascular thrombectomy registries from two academic referral centers, generating a combined cohort of 1977 patients. MLS was extracted from the original trial data or measured on computed tomography or magnetic resonance imaging that was obtained a median of 47.0 h (interquartile range 27.0-75.1 h) after stroke onset. Logistic regression was performed to identify predictors of poor outcome and the minimal clinically relevant MLS threshold.
RESULTS: The presence of MLS was a predictor of poor outcome, independent of baseline clinical and demographic factors (adjusted odds ratio 4.46, 95% confidence interval 3.56-5.59, p < 0.001). Examining the full range of MLS values identified, a value of greater than 3 mm was the critical threshold that significantly predicted poor outcome (adjusted odds ratio 3.20 [1.31-7.82], p = 0.011).
CONCLUSIONS: These results show that the presence of MLS predicts poor outcome and, specifically, MLS value greater than 3 mm is an important threshold across a variety of clinical settings. These findings may have relevance for the design and interpretation of future trials for antiedema therapies.
参考来源
- McKeown ME, Prasad A, Kobsa J, et al. Midline Shift Greater than 3 mm Independently Predicts Outcome After Ischemic Stroke. Neurocrit Care. 2021. PMID: 34494212. doi:10.1007/s12028-021-01341-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。